Fintel reports that on March 12, 2025, Exane BNP Paribas upgraded their outlook for Medical Properties Trust (NYSE:MPW) from ...

Exane BNP Paribas upgraded Adecco (AHEXY) to Outperform from Neutral with a CHF 33.50 price target The firm adjusted ratings in the staffing ...

Exane BNP Paribas analyst Andrew Grobler downgraded Equifax (EFX) to Neutral from Outperform with a $265 price target The firm adjusted ...

On Friday, BNP Paribas (OTC:BNPQY) Exane analyst Mourad Lahmidi upgraded AUTO1 Group SE (AG1:GR) (OTC: ATOGF) stock rating from Neutral to Outperform, setting a new price target at €30.00 ...

BNP Paribas’ THEAM Quant platform, in collaboration with BNP Paribas Exane Research, has launched the THEAM Quant – Nuclear ...

On Thursday, BNP Paribas (OTC:BNPQY) Exane analyst Warwick Okines downgraded Puma SE shares, listed on the Frankfurt Stock Exchange (PUM:GR) and over-the-counter (OTC: PMMAF (OTC:PMMAF)), from ...

The S&P 500 is on track for its worst week since September, the latter since November. Both are poised to fall for three ...

On Friday, BNP Paribas (OTC:BNPQY) Exane analyst Mourad Lahmidi upgraded AUTO1 Group SE (AG1:GR) (OTC: ATOGF) stock rating from Neutral to Outperform, setting a new price target at €30.00, a ...

Fintel reports that on March 12, 2025, Exane BNP Paribas upgraded their outlook for Medical Properties Trust (LSE:0JZZ) from Neutral to Outperform. As of March 3, 2025, the average one-year price ...